PERCEPTIVE ADVISORS LLC
SEC CIK 1224962 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMTX | Immatics N.V. | Dir | 11.25M | $7.50M | — | 1 | 2026-08-26 | 2026-08-26 |
| FRNM | Freenome, Inc. | 10% | 10.87M | — | — | 1 | 2026-07-20 | 2026-07-20 |
| KARD | Kardigan, Inc. | Dir | 20.7K | — | — | 1 | 2026-06-17 | 2026-06-17 |
| MGTX | MeiraGTx Holdings plc | Dir, 10% | 10.79M | — | — | 1 | 2026-04-17 | 2026-04-17 |
| LONA | LeonaBio, Inc. | Dir, 10% | 329.8K | — | — | 1 | 2025-12-23 | 2025-12-23 |
| ACRV | Acrivon Therapeutics, Inc. | 10% | 3.10M | — | $3.76M | 2 | 2025-04-25 | 2025-04-30 |
| ADGM | Adagio Medical Holdings, Inc. | Dir, 10% | 9.68M | — | — | 1 | 2025-01-22 | 2025-01-22 |
| VRCA | Verrica Pharmaceuticals Inc. | 10% | 6.72M | $10.20M | — | 2 | 2023-12-15 | 2023-12-21 |
| ALDX | Aldeyra Therapeutics, Inc. | 10% | 11.35M | $2.71M | — | 3 | 2022-07-29 | 2022-08-09 |
| ADMA | ADMA BIOLOGICS, INC. | 10% | 13.52M | — | $622.5K | 1 | 2021-09-24 | 2021-09-24 |
| YARW | Yarrow Bioscience, Inc. | 10% | 5.19M | — | $460.0K | 1 | 2021-08-13 | 2021-08-13 |
Most active insiders at IMTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | Dir | $7.50M | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-27 16:00 | 2026-08-26 | IMTX | Immatics N.V. | PERCEPTIVE ADVISORS LLC | Dir | P - Purchase | $8.69 | +863.1K | 11.25M | +8% | +$7.50M |
| I | 2026-07-22 21:08 | 2026-07-20 | FRNM | Freenome, Inc. | PERCEPTIVE ADVISORS LLC | 10% | A - Grant | $10.00 | +5.50M | 10.87M | +102% | +$55.00M |
| I | 2026-07-13 16:44 | 2026-06-17 | KARD | Kardigan, Inc. | PERCEPTIVE ADVISORS LLC | Dir | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 |
| DI | 2026-04-23 20:59 | 2026-04-17 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Dir, 10% | A - Grant | $9.00 | +555.6K | 10.79M | +5% | +$5.00M |
| DMI | 2025-12-23 | 2025-12-23 | LONA | LeonaBio, Inc. | PERCEPTIVE ADVISORS LLC | Dir, 10% | A - Grant | $6.35 | +1.32M | 329.8K | New | +$8.38M |
| MI | 2025-05-01 | 2025-04-30+ | ACRV | Acrivon Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | 10% | S - Sale | $1.38 | -736.8K | 3.10M | -19% | -$1.02M |
| MI | 2025-04-29 | 2025-04-25+ | ACRV | Acrivon Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | 10% | S - Sale | $1.81 | -1.52M | 3.84M | -28% | -$2.74M |
| 2025-02-14 | 2025-01-22 | ADGM | Adagio Medical Holdings, Inc. | PERCEPTIVE ADVISORS LLC | Dir, 10% | A - Grant | — | +64.2K | 9.68M | +0.7% | — | |
| MI | 2023-12-26 | 2023-12-21+ | VRCA | Verrica Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $6.45 | +504.7K | 6.72M | +8% | +$3.26M |
| MI | 2023-12-19 | 2023-12-15+ | VRCA | Verrica Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $5.63 | +1.23M | 6.00M | +26% | +$6.94M |
| MI | 2022-08-11 | 2022-08-09+ | ALDX | Aldeyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $7.55 | +115.0K | 11.35M | +1% | +$867.8K |
| I | 2022-08-03 | 2022-08-01 | ALDX | Aldeyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $5.05 | +144.2K | 10.39M | +1% | +$728.1K |
| I | 2022-08-02 | 2022-07-29 | ALDX | Aldeyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $5.03 | +222.1K | 10.25M | +2% | +$1.12M |
| MI | 2021-09-29 | 2021-09-24+ | ADMA | ADMA BIOLOGICS, INC. | PERCEPTIVE ADVISORS LLC | 10% | S - Sale | $1.25 | -500.0K | 13.52M | -4% | -$622.5K |
| I | 2021-08-17 | 2021-08-13 | YARW | Yarrow Bioscience, Inc. | PERCEPTIVE ADVISORS LLC | 10% | S - Sale | $1.84 | -250.0K | 5.19M | -5% | -$460.0K |
Purchase Sale Sale after option exercise All abbreviations